BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36075586)

  • 21. Does β-Cell Autoimmunity Play a Role in Cystic Fibrosis-Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry.
    Konrad K; Kapellen T; Lilienthal E; Prinz N; Bauer M; Thon A; Rietschel E; Wiemann D; Holl RW;
    Diabetes Care; 2016 Aug; 39(8):1338-44. PubMed ID: 27271187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study.
    Miller RJ; Tildesley HD; Wilcox PG; Zhang H; Kreisman SH
    Can Respir J; 2008 Sep; 15(6):291-4. PubMed ID: 18818782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for chronic kidney disease in adults with cystic fibrosis.
    Quon BS; Mayer-Hamblett N; Aitken ML; Smyth AR; Goss CH
    Am J Respir Crit Care Med; 2011 Nov; 184(10):1147-52. PubMed ID: 21799076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canadian Cystic Fibrosis-related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care.
    Potter KJ; Coriati A; Hicks P; Lands LC; McKinney ML; Boudreau V; Bonhoure A; Luca P; Ho J; Tagougui S; Jober A; Pohl M; Rosolowsky ET; Gilmour J; Lam GY; Stephenson AL; Senior PA; Rabasa-Lhoret R; Kherani T
    Can J Diabetes; 2023 Apr; 47(3):263-271.e1. PubMed ID: 36872137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term benefits in lung function and nutritional status of strict metabolic control of cystic fibrosis-related diabetes.
    Martín-Frías M; Máiz L; Carcavilla A; Barrio R
    Arch Bronconeumol; 2011 Oct; 47(10):531-4. PubMed ID: 21798655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis-related diabetes and lung disease: an update.
    Prentice BJ; Jaffe A; Hameed S; Verge CF; Waters S; Widger J
    Eur Respir Rev; 2021 Mar; 30(159):. PubMed ID: 33597125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic fibrosis related diabetes: Medical management.
    Ode KL; Chan CL; Granados A; Moheet A; Moran A; Brennan AL
    J Cyst Fibros; 2019 Oct; 18 Suppl 2():S10-S18. PubMed ID: 31679720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis-related diabetes mellitus: etiology, evaluation, and management.
    Fischman D; Nookala VK
    Endocr Pract; 2008 Dec; 14(9):1169-79. PubMed ID: 19158056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic Fibrosis-Related Diabetes in Poland.
    Rachel M; Biesiadecki M; Galiniak S
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis.
    Caley LR; Zagoya C; Duckstein F; White H; Shimmin D; Jones AM; Barrett J; Whitehouse JL; Floto RA; Mainz JG; Peckham DG
    J Cyst Fibros; 2023 Mar; 22(2):275-281. PubMed ID: 36710099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.
    Konrad K; Thon A; Fritsch M; Fröhlich-Reiterer E; Lilienthal E; Wudy SA; Holl RW;
    Diabetes Care; 2013 Apr; 36(4):879-86. PubMed ID: 23238661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality.
    Moran A; Dunitz J; Nathan B; Saeed A; Holme B; Thomas W
    Diabetes Care; 2009 Sep; 32(9):1626-31. PubMed ID: 19542209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).
    Mozzillo E; Franceschi R; Piona C; Passanisi S; Casertano A; Pjetraj D; Maltoni G; Calcaterra V; Cauvin V; Cherubini V; D'Annunzio G; Franzese A; Frongia AP; Lombardo F; Lo Presti D; Matteoli MC; Piccinno E; Predieri B; Rabbone I; Scaramuzza AE; Toni S; Zucchini S; Maffeis C; Schiaffini R
    Front Endocrinol (Lausanne); 2021; 12():673539. PubMed ID: 34017312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical updates in cystic fibrosis-related diabetes.
    Brennan AL; Beynon J
    Semin Respir Crit Care Med; 2015 Apr; 36(2):236-50. PubMed ID: 25826591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention.
    White H; Pollard K; Etherington C; Clifton I; Morton AM; Owen D; Conway SP; Peckham DG
    J Cyst Fibros; 2009 May; 8(3):179-85. PubMed ID: 19179122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis-related diabetes in childhood.
    O'Riordan SM; Dattani MT; Hindmarsh PC
    Horm Res Paediatr; 2010; 73(1):15-24. PubMed ID: 20190536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries.
    Volkova N; Moy K; Evans J; Campbell D; Tian S; Simard C; Higgins M; Konstan MW; Sawicki GS; Elbert A; Charman SC; Marshall BC; Bilton D
    J Cyst Fibros; 2020 Jan; 19(1):68-79. PubMed ID: 31196670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
    Moheet A; Moran A
    Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose intolerance in cystic fibrosis patients.
    Lanng S
    Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.